Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Other Accumulated Expenses (2022 - 2026)

Argan (AGX) has disclosed Other Accumulated Expenses for 5 consecutive years, with $7.9 million as the latest value for Q1 2026.

  • Quarterly Other Accumulated Expenses fell 59.02% to $7.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Jan 2026, down 59.02% year-over-year, with the annual reading at $7.9 million for FY2026, 59.02% down from the prior year.
  • Other Accumulated Expenses hit $7.9 million in Q1 2026 for Argan, up from $7.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $25.6 million in Q2 2025 to a low of $7.5 million in Q4 2025.
  • Historically, Other Accumulated Expenses has averaged $12.7 million across 5 years, with a median of $11.8 million in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: surged 122.06% in 2025 and later plummeted 59.02% in 2026.
  • Year by year, Other Accumulated Expenses stood at $13.4 million in 2022, then decreased by 17.19% to $11.1 million in 2023, then grew by 14.39% to $12.7 million in 2024, then crashed by 40.81% to $7.5 million in 2025, then rose by 4.73% to $7.9 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for AGX at $7.9 million in Q1 2026, $7.5 million in Q4 2025, and $18.4 million in Q3 2025.